NEW ISSUE
The ISCHEMIA trial in real-world practice, a new “uncaging” coronary stent, PCI of the LM trifurcation in the EXCEL trial and more...
December 18, 2020
Department of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Severe aortic stenosis (AS) is frequently present in the ageing population and is related to mortality and morbidity. Traditionally, this disease has been treated with surgical aortic valve replacement (SAVR); however, during the last decade the field has been revolutionised by the less invasive transcatheter aortic valve implantation (TAVI). The number of TAVI procedures is increasing rapidly and, as the boundaries of TAVI are continuously pushed, there is an increased need for knowledge on how to deal with comorbidities.
Concomitant coronary artery disease (CAD) is a frequent comorbidity observed in up to 50% of patients selected for TAVI1. The ...
Sign in to read and download the full article
Forgot your password?No account yet? Sign up for free!
Create my pcr account Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com
Read next article
Sizing for self-expanding transcatheter aortic valve implantation